Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.7800
+0.0211 (2.78%)
Jan 14, 2026, 12:58 PM EST - Market open
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $21.11 million as of January 14, 2026. Its market cap has decreased by -72.34% in one year.
Market Cap
21.11M
Enterprise Value
21.13M
1-Year Change
-72.34%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $21.11M, a decrease of -93.90%. That is a compound annual growth rate of -45.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 20.54M | 24.41% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | 346.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.27B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.28B |
| UnitedHealth Group | 307.89B |
| AstraZeneca | 295.57B |
| Novartis AG | 274.30B |
| Merck & Co. | 270.47B |
| Novo Nordisk | 263.26B |